Market revenue in 2023 | USD 54,315.2 million |
Market revenue in 2030 | USD 110,131.4 million |
Growth rate | 10.6% (CAGR from 2023 to 2030) |
Largest segment | Targeted delivery |
Fastest growing segment | Targeted Delivery |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to controlled release drug delivery market will help companies and investors design strategic landscapes.
targeted delivery was the largest segment with a revenue share of 24.25% in 2023. Horizon Databook has segmented the Global controlled release drug delivery market based on wurster technique, coacervation, micro encapsulation, implants, transdermal, targeted delivery covering the revenue growth of each sub-segment from 2018 to 2030.
Constantly rising R&D expenditure by pharmaceutical development companies that are focused on development of efficient therapy for chronic and non-communicable complications such as cancer, diabetes, and hypertension are expected to boost the market growth over the forecast period.
For instance, Taris an R&D based biomedical company pipeline product TAR-200 (Gemcitabine) indicated for the treatment of bladder cancer includes a controlled release drug delivery system. Furthermore, it is expected that Johnson & Johnson will complete the acquisition of Taris Biomedical in 2020. It lead investigational product TAR-200 is reported to be one of the main reasons behind the acquisition.
Horizon Databook provides a detailed overview of global-level data and insights on the Global controlled release drug delivery market , including forecasts for subscribers. This global databook contains high-level insights into Global controlled release drug delivery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account